TY - JOUR
T1 - Erratum: SGLT2 inhibitors in combination therapy: From mechanisms to clinical considerations in type 2 diabetes management. (Diabetes Care (2018) 41 (1543–1556) DOI: 10.2337/dc18-0588)
AU - van Baar, Michaël J. B.
AU - van Ruiten, Charlotte C.
AU - Muskiet, Marcel H. A.
AU - van Bloemendaal, Liselotte
AU - IJzerman, Richard G.
AU - van Raalte, Daniël H.
PY - 2019/10/1
Y1 - 2019/10/1
N2 - In the article cited above, Fig. 3 was replaced. The data in the HbA1c (%) panel under 8.9 baseline was corrected. The online version of the article (https://doi.org/10.2337/dc18-0588) has been corrected.
AB - In the article cited above, Fig. 3 was replaced. The data in the HbA1c (%) panel under 8.9 baseline was corrected. The online version of the article (https://doi.org/10.2337/dc18-0588) has been corrected.
UR - http://www.scopus.com/inward/record.url?scp=85072546771&partnerID=8YFLogxK
U2 - https://doi.org/10.2337/dc19-10a
DO - https://doi.org/10.2337/dc19-10a
M3 - Comment/Letter to the editor
C2 - 31431451
SN - 0149-5992
VL - 42
SP - 2015
JO - Diabetes Care
JF - Diabetes Care
IS - 10
ER -